Navigation Links
PsiPort ™ Mass Directed Auto Purification Software from Shimadzu Biotech

ProductsPsiPort ™ Mass Directed Auto Purification Software from Shimadzu Biotech
Company Shimadzu Biotech
Item PsiPort ™ Mass Directed Auto Purification Software
Price 
Description Shimadzu Biotech presents PsiPort Mass Directed Auto Purification software, a web-based data review and data acquisition system designed for automated compound isolation and purification for the life science and pharmaceutical discovery programs. The system has been designed specifically to simplify high throughput mass directed auto purification for synthetic chemists using a simple, intuitive, graphical user interface operating within Internet Explorer. PsiPort is the Web-based solution for sample log-in and interactive data review (Microsoft Internet Explorer browser shows MS chromatogram, MS spectrum, UV chromatogram and associated fraction id) and features a fully distributed client-server architecture for data review either within a secure company intranet or over the Internet.

Key features

  • Chemists and biochemists do not need to be trained on mass spectrometry software.
  • Web-based solution for sample log-in and interactive data review (Microsoft Internet Explorer browser shows MS chromatogram, MS spectrum, UV chromatogram and associated fraction id).
  • Automates compound isolation and purification through a single web-based interface (enter target mass information through a wizard or use Microsoft Excel).
  • Fully distributed client-server architecture for data review either within a secure company intranet or over the Internet.
Software design
PsiPort Mass Directed Auto Purification software has been designed in a two tier approach to accelerating compound isolation and purification through a generic web based interface.

Access to PsiPort
Access to the PsiPort system is managed and controlled by the System Manager | Administrator to provide full system security. Access can be either local or remote using the integrated client-server support (Microsoft Internet Information Services).

Sample log-in and acquisition
Chemists may submit samples either using a spreadsheet from an external database (Microsoft Excel for example) or a wizard function for a limited number of samples. Each sample contains all the user defined acquisition information (for example target mass, formulae, MS and UV thresholds and a pre-assigned LC/MS method which also includes a specific customized report layout).

Info Shimadzu BiotechShimadzu Biotech
Japan/Asia
Shimadzu Corporation
1 Nishinokyo Kuwabaracho
Nakagyoku, Kyoto 604-8511
Japan
Phone: +81-75-823-1148
Fax: +81-75-823-1364
info@shimadzu-biotech.net

United States
Shimadzu Biotech USA
7102 Riverwood Drive
Columbia, Maryland 21046 USA
Phone: 800-477-1227/410-381-1227
info@shimadzu-biotech.net

England
Shimadzu Biotech
Wharfside
Trafford Wharf Road
Manchester
M17 1GP
England
Tel +44 161 888 4414
Fax +44 161 888 4402
MALDI
chris.sutton@kratos.co.uk
LCMS
nl@shimadzu.de

For contacts in other regions
please click here.

Customer Service: see above
Fax Number: see above
Web Site: http://www.shimadzu-biotech.net
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Cleland’s REDUCTACRYL™ Reagent from Calbiochem
2. Transformance™ competent cell preparation service from Lucigen
3. EvoQuest ™ Custom Laboratory Services from Invitrogen
4. GST•Tag™ Antibody Plate from Novagen
5. pTriEx™-4 DNA from Novagen
6. ReBlot™ Plus Kit - Trial from CHEMICON
7. NanoMate ™ 100 with ESI Chip Technology from Advion Biosciences, Inc.
8. GrabIt™ Protein G Plus/Protein A Kit from Novagen
9. Cell invasion Fluorometric (green) Assay Kit, InnoCyte™ from Calbiochem
10. mirVana™ miRNA Bioarray Essentials Kit from Ambion
11. CaspaTag™ Pan-Caspase In Situ Assay Kit, Sulforhodamine from CHEMICON
Rabbit polyclonal to Tryptophanyl tRNA synthetase ( Abpromise for all tested applications). Antigen: Recombinant full length protein (Human): Tryptophanyl tRNA synthetase Entrez Gene ID: 745...
Mouse monoclonal [CIa] to Ia Antigen (Biotin) ( Abpromise for all tested applications)....
RNA polymerase sigma 70 Immunogen: Recombinant, full length protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse monoclonal to Factor V Heavy Chain Immunogen: Purified human Factor V. Specificity: This antibody reacts with the activation C peptide (mw ~150,000) in the heavy chain of thrombin-cleave...
Biology Products:
(Date:4/2/2015)... BETHESDA, Md. , April 2, 2015 ... Salt Lake City , the American ... election of five new directors to its Board.  Members ... for the ACMG and for forming and advancing its ... the medical genetics profession. "It,s an eventful ...
(Date:3/31/2015)... NEW YORK , March 31, 2015  Elephant ... the "Company"), a global provider of Software Defined Network ... solutions, today announced total revenue of approximately $20.4 million ... to a restated $19.5 million for the year ended ... of calendar 2014, the Company had completed its multi-year ...
(Date:3/24/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ) has ... Global Strategic Business Report" report to their offering. ... in US$ Thousands by the following Segments: Face Biometrics, and Voice ... Canada , Japan , ... East & Africa , and ...
Breaking Biology News(10 mins):American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6
... that have died in mass strandings in New Zealand ... a new study concludes, challenging a popular assumption that ... almost certain death because of familial ties. Using ... determined that both related and unrelated individuals were scattered ...
... , Francisella tularensis , the cause of tularemia ... considered a potential biological weapon because it is readily aerosolized ... humans. While a live attenuated vaccine strain has been ... understand the basis for its attenuated virulence. In an ...
... engineers are developing the right mix to reduce concrete,s ... biofuel byproducts. "The idea is to use bioethanol ... concrete as a partial replacement of cement," said Feraidon ... using these materials we can reduce the carbon footprint ...
Cached Biology News:Study questions the role of kinship in mass strandings of pilot whales 2Study questions the role of kinship in mass strandings of pilot whales 3News tips from the journal mBio®, volume 4, issue 1 2Researchers building stronger, greener concrete with biofuel byproducts 2Researchers building stronger, greener concrete with biofuel byproducts 3
(Date:4/23/2015)... , April 23, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... report its first quarter 2015 results before the Nasdaq ... then host a live conference call and webcast to discuss ... morning, April 30, 2015 at 8:00 a.m. Eastern Time ... the live conference call by dialing 866-952-1906 (US) or ...
(Date:4/23/2015)... FRANCISCO, Calif. , April 23, 2015  Veracyte, Inc. ... entered into a definitive agreement to sell approximately $40 ... Under the agreement, the investors will purchase an aggregate ... price of $8.15 per share, the closing stock price ... by new and existing investors, including Broadfin Capital, Camber ...
(Date:4/23/2015)... HOUSTON , April 23, 2015  Metanome, ... today announced the company has changed its name ... reflect Diversigen,s positioning as the single commercial source ... need to capitalize on the diverse opportunities of ... types that Diversigen accepts – including those that ...
(Date:4/23/2015)... Delpor, Inc. (Delpor), a biotechnology company ... States Patent and Trademark Office has issued 2 new ... US Pat. No. 8,986,727 was issued on March ... device for the sustained release of therapeutic agents. ... sustained (zero-order) release of large and small molecules for ...
Breaking Biology Technology:Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2015 Results 2Veracyte, Inc. Announces $40 Million Private Placement 2Veracyte, Inc. Announces $40 Million Private Placement 3Veracyte, Inc. Announces $40 Million Private Placement 4Metanome Announces Corporate Name Change to Diversigen 2Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device 2Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device 3